US FDA approves Sanofi's genetic disorder drug
SNY•The US FDA approved Sanofi's oral drug venglustat, the first treatment for a type of rare genetic condition affecting the brain and nervous system.
1. FDA approval
The US FDA approved Sanofi's oral drug venglustat on Wednesday, making it the first treatment for a type of rare genetic condition that affects the brain and nervous system.




